Federal health officials revised the U.S. childhood immunization schedule, narrowing universal recommendations from 17 vaccines to 11, according to a White House‑directed review. Under the change, shots for diseases such as influenza, RSV and rotavirus shift toward shared clinical decision‑making or targeted recommendations for high‑risk groups rather than blanket universal endorsement. The policy was issued by HHS and the CDC and has drawn immediate concern from industry and clinical groups about downstream effects on vaccination uptake and public health messaging. The change will also shape manufacturers’ commercial planning and public‑education efforts; stakeholders have flagged the need for clear evidence briefings and transparent advisory processes as the revisions move into practice.